4.3 Review

Transformations of marginal zone lymphomas and lymphoplasmacytic lymphomas: Report from the 2021 SH/EAHP Workshop

相关参考文献

注意:仅列出部分参考文献,下载原文获取全部文献信息。
Review Pathology

Composite Classic Hodgkin Lymphoma and Follicular Lymphoma A Clinicopathologic Study of 22 Cases With Review of 27 Additional Cases in the Literature

Yuhua Huang et al.

Summary: Composite classic Hodgkin lymphoma and follicular lymphoma (CHLFL) is a rare entity that predominantly occurs in older adults, involves lymph nodes, and most commonly presents as de novo cases. In a small number of cases assessed, the CHL and FL components are usually clonally related.

AMERICAN JOURNAL OF SURGICAL PATHOLOGY (2022)

Review Hematology

Marginal zone lymphoma: present status and future perspectives

Chan Y. Cheah et al.

HAEMATOLOGICA (2022)

Article Pathology

Genomic landscape of Epstein-Barr virus-positive extranodal marginal zone lymphomas of mucosa-associated lymphoid tissue

Bryan Rea et al.

Summary: EBV-positive MALT lymphomas are rare and genetically non-complex, usually associated with transplant or immunodeficiency. They often have mutations or copy number abnormalities in IRF family or interacting genes.

MODERN PATHOLOGY (2022)

Review Medicine, General & Internal

Marginal-Zone Lymphomas

Davide Rossi et al.

Summary: Marginal-Zone Lymphomas, the third most common lymphoma, are usually indolent and often associated with chronic antigenic stimulation. Some cases regress with treatment of the infection, while patients with genetic lesions are treated with chemoimmunotherapy.

NEW ENGLAND JOURNAL OF MEDICINE (2022)

Article Hematology

Clinico-biological features and outcome of patients with splenic marginal zone lymphoma with histological transformation

Gabriela Bastidas-Mora et al.

Summary: The study describes 36 patients with splenic marginal zone lymphoma (SMZL) with transformation, with predictors including cytopenias, hypoalbuminaemia, and complex karyotype. Patients with SMZL-T have a higher risk of death, mostly developing diffuse large B-cell lymphoma post transformation, with predictors for worse survival being high-risk International Prognostic Index and lack of complete response.

BRITISH JOURNAL OF HAEMATOLOGY (2022)

Article Hematology

The International Consensus Classification of Mature Lymphoid Neoplasms: a report from the Clinical Advisory Committee

Elias Campo et al.

Summary: Since 1994, the classification of lymphoid neoplasms has been continuously updated through international efforts, with recent progress driven by genomic studies. This proposal presents the International Consensus Classification of mature lymphoid, histiocytic, and dendritic cell tumors, which has refined diagnostic criteria and incorporated new insights from genomics.
Article Hematology

Hodgkin lymphoma arising in patients with chronic lymphocytic leukemia: outcomes from a large multi-center collaboration

Deborah M. Stephens et al.

Summary: Chronic lymphocytic leukemia (CLL) patients who develop Hodgkin lymphoma (HL) have limited survival with no current therapeutic standard of care. A multi-center retrospective study of patients with Hodgkin transformation (HT) of CLL showed that those treated with ABVD-based regimens had prolonged survival, supporting the use of these regimens as standard of care for these patients.

HAEMATOLOGICA (2021)

Review Oncology

CXCR4 in Waldenstrom's Macroglobulinema: chances and challenges

Lisa Marie Kaiser et al.

Summary: WM is an incurable B-cell neoplasm characterized by mutations in MYD88 and CXCR4 genes. Understanding the molecular landscape of WM has paved the way for predicting treatment response to drugs like ibrutinib and developing novel therapeutic approaches. The role of CXCR4 in WM biology, prognostic and predictive relevance, and therapeutic implications have been highlighted in recent research.

LEUKEMIA (2021)

Review Cell Biology

The role of EBV in haematolymphoid proliferations: emerging concepts relevant to diagnosis and treatment

Emad Ababneh et al.

Summary: Epstein-Barr virus (EBV) is a highly prevalent gamma herpesvirus worldwide, with a small percentage of infected individuals developing EBV-associated neoplasms. Advances in understanding EBV-host interactions and mechanisms of lymphomagenesis are helping to improve diagnostic methods for EBV-related tumors.

HISTOPATHOLOGY (2021)

Review Oncology

A Review on Splenic Diffuse Red Pulp Small B-Cell Lymphoma

Elif Yilmaz et al.

Summary: Splenic diffuse red pulp small B-cell lymphoma (SDRPL) is a rare disease, difficult to diagnose without splenic tissue examination. It has distinct immunophenotypic features that differentiate it from other types of lymphomas, with no standard treatment regimen established yet, suggesting a need for further research into effective therapeutic approaches.

CURRENT ONCOLOGY (2021)

Letter Pathology

Transformation of a splenic marginal zone lymphoma into classic Hodgkin lymphoma

Thomas Menter et al.

JOURNAL OF CLINICAL PATHOLOGY (2019)

Article Oncology

Lymphoplasmacytic Lymphoma and Marginal Zone Lymphoma

Luis M. Juarez-Salcedo et al.

HEMATOLOGY-ONCOLOGY CLINICS OF NORTH AMERICA (2019)

Article Hematology

Transformation of marginal zone lymphoma (and association with other lymphomas)

Carla Casulo et al.

BEST PRACTICE & RESEARCH CLINICAL HAEMATOLOGY (2017)

Article Hematology

Genetic basis of PD-L1 overexpression in diffuse large B-cell lymphomas

Konstantinos Georgiou et al.

Article Oncology

Histologic transformation in marginal zone lymphomas

A. Conconi et al.

ANNALS OF ONCOLOGY (2015)

Article Pathology

MYD88 L265P mutation analysis helps define nodal lymphoplasmacytic lymphoma

Fatima Hamadeh et al.

MODERN PATHOLOGY (2015)

Article Pathology

Lymphoplasmacytic Lymphoma and Other Non-Marginal Zone Lymphomas With Plasmacytic Differentiation

Pei Lin et al.

AMERICAN JOURNAL OF CLINICAL PATHOLOGY (2011)

Article Pathology

Spienic small B-cell lymphoma with IGH/BCL3 translocation

LA Soma et al.

HUMAN PATHOLOGY (2006)